Podcast
Questions and Answers
Classical Hodgkin's Disease is composed of two different disease entities: Classical HD and ________.
Classical Hodgkin's Disease is composed of two different disease entities: Classical HD and ________.
Mixed cellularity (MC) Hodgkin's Disease
In Hodgkin's Disease, the bimodal age distribution shows the first peak between the ________ of life.
In Hodgkin's Disease, the bimodal age distribution shows the first peak between the ________ of life.
2nd - 3rd decade
In Non-Hodgkin's Lymphoma, the Ann Arbor Staging System is commonly used for staging the disease based on the extent of ________ involvement.
In Non-Hodgkin's Lymphoma, the Ann Arbor Staging System is commonly used for staging the disease based on the extent of ________ involvement.
lymph node
Adverse prognostic features in Hodgkin's Disease include presence of ________ symptoms.
Adverse prognostic features in Hodgkin's Disease include presence of ________ symptoms.
Signup and view all the answers
Reactive hyperplasia, Chronic lymphadenitis, and Infectious mononucleosis are differential diagnoses of ________ disease.
Reactive hyperplasia, Chronic lymphadenitis, and Infectious mononucleosis are differential diagnoses of ________ disease.
Signup and view all the answers
In Hodgkin's Disease, the male to female ratio is 2:1 in kids, while in adults it is ________.
In Hodgkin's Disease, the male to female ratio is 2:1 in kids, while in adults it is ________.
Signup and view all the answers
Nodular Sclerosing Hodgkin Lymphoma is characterized by lacunar cells in nodular sclerosis Hodgkin’s lymphoma and is a type of ________ disease.
Nodular Sclerosing Hodgkin Lymphoma is characterized by lacunar cells in nodular sclerosis Hodgkin’s lymphoma and is a type of ________ disease.
Signup and view all the answers
In the Ann Arbor Staging System, Stage I involves the involvement of a single lymph node region or a single extralymphatic organ or site (IE), while Stage II involves ________.
In the Ann Arbor Staging System, Stage I involves the involvement of a single lymph node region or a single extralymphatic organ or site (IE), while Stage II involves ________.
Signup and view all the answers
Stage III in the Ann Arbor Staging System for Hodgkin's Disease involves the involvement of lymph node regions on both sides of the diaphragm which may be accompanied by involvement of the spleen (IIIS) or by localized involvement of an extralymphatic organ or site (IIIE) or ________.
Stage III in the Ann Arbor Staging System for Hodgkin's Disease involves the involvement of lymph node regions on both sides of the diaphragm which may be accompanied by involvement of the spleen (IIIS) or by localized involvement of an extralymphatic organ or site (IIIE) or ________.
Signup and view all the answers
In the Ann Arbor Staging System, Stage IV is characterized by diffuse or disseminated involvement of one or more extra lymphatic organs or tissues with or without associated lymph node involvement. Stage IV is an example of a stage that involves ________.
In the Ann Arbor Staging System, Stage IV is characterized by diffuse or disseminated involvement of one or more extra lymphatic organs or tissues with or without associated lymph node involvement. Stage IV is an example of a stage that involves ________.
Signup and view all the answers
B symptoms in Hodgkin's Disease are defined as fever > 38ºC for three consecutive days, drenching night sweats, or unexplained loss of ________ or more of weight the preceding 6 months.
B symptoms in Hodgkin's Disease are defined as fever > 38ºC for three consecutive days, drenching night sweats, or unexplained loss of ________ or more of weight the preceding 6 months.
Signup and view all the answers
The lymphocyte depletion type of Hodgkin’s lymphoma is characterized by numerous atypical cells present in a densely fibrotic stroma with scanty ________.
The lymphocyte depletion type of Hodgkin’s lymphoma is characterized by numerous atypical cells present in a densely fibrotic stroma with scanty ________.
Signup and view all the answers
Lymphocyte-predominant Hodgkin’s (LPHD), making up ~ 5% of cases A common factor of both HD types is that neoplastic cells constitute only a small minority of the cells in the affected tissue, often corresponding to < 2% of the total tumor. % OF PATIENTS Most commonly involved lymph nodes are the cervical and supraclavicular in 75%. Bone marrow is involved in ___% of patients.
Lymphocyte-predominant Hodgkin’s (LPHD), making up ~ 5% of cases A common factor of both HD types is that neoplastic cells constitute only a small minority of the cells in the affected tissue, often corresponding to < 2% of the total tumor. % OF PATIENTS Most commonly involved lymph nodes are the cervical and supraclavicular in 75%. Bone marrow is involved in ___% of patients.
Signup and view all the answers
Hodgkin’s Disease/Lymphoma is a fatal disease with ___% of untreated patients dying within 2 to 3 years. With chemotherapy, >80% of patients suffering from HD are cured.
Hodgkin’s Disease/Lymphoma is a fatal disease with ___% of untreated patients dying within 2 to 3 years. With chemotherapy, >80% of patients suffering from HD are cured.
Signup and view all the answers
HD nearly always arises and disseminates in lymph nodes. Contiguous spread via the lymphatic chain e.g. involvement of abdominal & thoracic LNs. Hodgkin Disease/Lymphoma “Classic” Hodgkin’s Disease nodular sclerosis mixed cellularity lymphocyte depleted classical lymphocyte rich HRS cells CD30 and CD15 positive. Nodular lymphocyte predominant HRS cells (L&H cells) have B cell markers CD 20 and surface Immunoglobulin Classic Hodgkin Lymphoma (mixed cellularity) Presence of the EBV genome in a case of ___ lymphoma as demonstrated immunohistochemically by the detection of LMP1 antigen.
HD nearly always arises and disseminates in lymph nodes. Contiguous spread via the lymphatic chain e.g. involvement of abdominal & thoracic LNs. Hodgkin Disease/Lymphoma “Classic” Hodgkin’s Disease nodular sclerosis mixed cellularity lymphocyte depleted classical lymphocyte rich HRS cells CD30 and CD15 positive. Nodular lymphocyte predominant HRS cells (L&H cells) have B cell markers CD 20 and surface Immunoglobulin Classic Hodgkin Lymphoma (mixed cellularity) Presence of the EBV genome in a case of ___ lymphoma as demonstrated immunohistochemically by the detection of LMP1 antigen.
Signup and view all the answers
Hodgkin’s Disease/Lymphoma Clinical Presentation SIGNS & SYMPTOMS Lymphadenopathy Mediastinal mass “B” symptoms Fever, weight loss, night sweats Hepatosplenomegaly % OF PATIENTS 90 60 30 25. Most commonly involved lymph nodes are the cervical and supraclavicular in ___%.
Hodgkin’s Disease/Lymphoma Clinical Presentation SIGNS & SYMPTOMS Lymphadenopathy Mediastinal mass “B” symptoms Fever, weight loss, night sweats Hepatosplenomegaly % OF PATIENTS 90 60 30 25. Most commonly involved lymph nodes are the cervical and supraclavicular in ___%.
Signup and view all the answers
Pathogenesis of HD is still largely unknown. HD nearly always arises and disseminates in lymph nodes. Contiguous spread via the lymphatic chain e.g. involvement of abdominal & thoracic LNs. Hodgkin Disease/Lymphoma “Classic” Hodgkin’s Disease nodular sclerosis mixed cellularity lymphocyte depleted classical lymphocyte rich HRS cells CD30 and CD15 positive. Nodular lymphocyte predominant HRS cells (L&H cells) have B cell markers CD 20 and surface Immunoglobulin Classic Hodgkin Lymphoma (mixed cellularity) Presence of the EBV genome in a case of Hodgkin’s lymphoma as demonstrated immunohistochemically by the detection of ___ antigen.
Pathogenesis of HD is still largely unknown. HD nearly always arises and disseminates in lymph nodes. Contiguous spread via the lymphatic chain e.g. involvement of abdominal & thoracic LNs. Hodgkin Disease/Lymphoma “Classic” Hodgkin’s Disease nodular sclerosis mixed cellularity lymphocyte depleted classical lymphocyte rich HRS cells CD30 and CD15 positive. Nodular lymphocyte predominant HRS cells (L&H cells) have B cell markers CD 20 and surface Immunoglobulin Classic Hodgkin Lymphoma (mixed cellularity) Presence of the EBV genome in a case of Hodgkin’s lymphoma as demonstrated immunohistochemically by the detection of ___ antigen.
Signup and view all the answers
Most commonly involved lymph nodes are the cervical and supraclavicular in 75%. Bone marrow is involved in 5% of patients. Hodgkin’s Disease/Lymphoma Clinical Presentation SIGNS & SYMPTOMS Lymphadenopathy Mediastinal mass “B” symptoms Fever, weight loss, night sweats Hepatosplenomegaly % OF PATIENTS 90 60 30 25. Hodgkin’s Disease/Lymphoma is a fatal disease with 90% of untreated patients dying within 2 to 3 years. With chemotherapy, >80% of patients suffering from HD are cured.Pathogenesis of HD is still largely unknown. HD nearly always arises and disseminates in lymph nodes Contiguous spread via the lymphatic chain e.g. involvement of abdominal & thoracic LNs Hodgkin Disease/Lymphoma “Classic” Hodgkin’s Disease nodular sclerosis mixed cellularity lymphocyte depleted classical lymphocyte rich HRS cells CD30 and CD15 positive. Nodular lymphocyte predominant HRS cells (L&H cells) have B cell markers CD 20 and surface Immunoglobulin Classic Hodgkin Lymphoma (mixed cellularity) Presence of the ___ genome in a case of Hodgkin’s lymphoma as demonstrated immunohistochemically by the detection of LMP1 antigen.
Most commonly involved lymph nodes are the cervical and supraclavicular in 75%. Bone marrow is involved in 5% of patients. Hodgkin’s Disease/Lymphoma Clinical Presentation SIGNS & SYMPTOMS Lymphadenopathy Mediastinal mass “B” symptoms Fever, weight loss, night sweats Hepatosplenomegaly % OF PATIENTS 90 60 30 25. Hodgkin’s Disease/Lymphoma is a fatal disease with 90% of untreated patients dying within 2 to 3 years. With chemotherapy, >80% of patients suffering from HD are cured.Pathogenesis of HD is still largely unknown. HD nearly always arises and disseminates in lymph nodes Contiguous spread via the lymphatic chain e.g. involvement of abdominal & thoracic LNs Hodgkin Disease/Lymphoma “Classic” Hodgkin’s Disease nodular sclerosis mixed cellularity lymphocyte depleted classical lymphocyte rich HRS cells CD30 and CD15 positive. Nodular lymphocyte predominant HRS cells (L&H cells) have B cell markers CD 20 and surface Immunoglobulin Classic Hodgkin Lymphoma (mixed cellularity) Presence of the ___ genome in a case of Hodgkin’s lymphoma as demonstrated immunohistochemically by the detection of LMP1 antigen.
Signup and view all the answers
